SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q3 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −4 vs. Q2 2023
- Shares held
- 3.82M
- −134.7K (−3.4%) vs. Q2 2023
- Total value
- $2.41M
- −$872.0K (−26.5%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 7
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 69 | $43 | 0.00% | +69 | New |
| GWM Advisors LLC | 145 | $91 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 268 | $169 | 0.00% | +21+8.5% | Added |
| FMR LLC | 343 | $216 | 0.00% | +343 | New |
| Harbour Investments, Inc. | 500 | $315 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 927 | $584 | 0.00% | +46+5.2% | Added |
| Gs Investments, Inc. | 2,000 | $1.26K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,094 | $3.00K | 0.00% | −274−5.1% | Reduced |
| 1st Source Bank | 10,000 | $6.30K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $6.30K | 0.00% | 00.0% | Unchanged |
| Elgethun Capital Management | 9,935 | $6.36K | 0.00% | 00.0% | Unchanged |
| Nadler Financial Group, Inc. | 13,750 | $8.66K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 14,940 | $9.41K | 0.00% | +395+2.7% | Added |
| Strategic Financial Concepts, LLC | 15,027 | $9.47K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,406 | $9.71K | 0.00% | −1,900−11.0% | Reduced |
| Charles Schwab Investment Management Inc | 16,238 | $10.2K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 21,000 | $13.2K | 0.00% | 00.0% | Unchanged |
| LGL Partners, LLC | 23,000 | $14.5K | 0.00% | 00.0% | Unchanged |
| Brookstone Capital Management | 21,755 | $17.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $28.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 46,673 | $29.4K | 0.00% | +27,777+147.0% | Added |
| Creative Planning | 47,518 | $29.9K | 0.00% | 00.0% | Unchanged |
| Peapack Gladstone Financial Corp | 52,296 | $33.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 52,643 | $33.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 58,100 | $37.0K | 0.00% | +3,700+6.8% | Added |
| Mariner, LLC | 69,000 | $43.5K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 73,470 | $46.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $51.2K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 192,027 | $121.0K | 0.02% | 00.0% | Unchanged |
| First Manhattan Co | 277,777 | $175.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 356,364 | $224.6K | 0.00% | +55,835+18.6% | Added |
| Pathstone Family Office, LLC | 506,513 | $319.1K | 0.00% | +506,513 | New |
| First PREMIER Bank | 807,535 | $509.0K | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 976,938 | $615.5K | 0.00% | +14,200+1.5% | Added |
| Veritable, L.P. | 0 | $0 | 0.00% | −506,513−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −84,000−100.0% | Sold out |
| Silver Oak Securities, Inc | 0 | $0 | 0.00% | −51,891−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −36,200−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,897−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −25,094−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,865−100.0% | Sold out |